Related Experiment Video
Updated: Feb 28, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Defining the Data set Defines the QSAR Claim
Manal A Nael1,2, Laxman M Alakonda2, Khaled M Elokely2
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt.
None:
Machine learning has greatly expanded QSAR modeling, but predictive claims still depend on choices that are rarely documented: how chemicals are represented, how end points are defined, and how evaluations are designed. In the era of benchmarks and foundation models, inconsistent standardization, unclear rules for combining measurements, and hidden information leakage routinely inflate reported performance while obscuring weaknesses that matter for real-world applications. We propose data set contracts: executable, auditable documents that explicitly declare chemical processing rules, end point definitions, aggregation logic, data splits, and leakage diagnostics for the intended prediction scenario. These contracts are feasible with current open-source tools and would shift the field from architecture-centric comparisons toward claims that are transparent, reproducible, and trustworthy.
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2D NMR: Heteronuclear Single-Quantum Correlation Spectroscopy (HSQC)
Statgraphics
Quantitative Aspects of Drug-Receptor Interaction
VSEPR Theory and the Basic Shapes

